NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

US STOCKS-Wall St set to rise on stimulus hopes; Alibaba falls on China probe

Published 24/12/2020, 14:52
© Reuters.
BIDU
-
ALT
-
JD
-
PDD
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window.)
* U.S.-listed Chinese firms fall on China's Alibaba probe
* Big banks gain on recovery hopes
* Futures up: Dow 0.13%, S&P 0.14%, Nasdaq 0.10%

(Adds comment; updates share prices)
By Ambar Warrick and Devik Jain
Dec 24 (Reuters) - Wall Street's main indexes were set to
open higher on Thursday on hopes of a bigger coronavirus
economic relief package, while Alibaba slumped after China
launched an antitrust investigation into the e-commerce giant.
Democrats in the U.S. House of Representatives aim to win
quick passage of legislation providing $2,000 in direct payments
to Americans after President Donald Trump unexpectedly insisted
on the provision. Congress had on Monday overwhelmingly approved an $892
billion emergency coronavirus aid bill that contained a
one-time, $600 payment to individuals.
"The market's hope of a bigger stimulus package will
probably make for a positive trading session. It's half a day,
and I don't expect too much action," said Peter Cardillo, chief
market economist at Spartan Capital Securities in New York.
Alibaba Group BABA.N plunged nearly 10% in pre-market
trading after China launched an antitrust investigation into the
company as part of an accelerating crackdown on anticompetitive
behavior. The news also pulled down U.S.-listed shares of other
Chinese companies like Baidu Inc BIDU.O , Pinduoduo Inc PDD.O
and JD.com Inc JD.O .
Markets will close at 1:00 PM ET on Thursday and will be
closed for Christmas holiday on Friday.
At 8:20 a.m. ET, Dow e-minis 1YMcv1 were up 40 points, or
0.13%, S&P 500 e-minis EScv1 were up 5 points, or 0.14%, and
Nasdaq 100 e-minis NQcv1 were up 13 points, or 0.1%.
Investors also cheered reports that Britain and the European
Union were on the cusp of striking a narrow Brexit trade deal.

The S&P 500 and the Dow ended higher on Wednesday as
investors pivoted to cyclical stocks that stand to benefit most
during a recovery, encouraged by COVID-19 vaccine rollouts and
passing of the coronavirus relief bill.
"The rotation (into cyclicals) is probably going to
continue, and that could happen next week when we have window
dressing at the end of the quarter," Cardillo said.
Big banks Morgan Stanley MS.N , JPMorgan Chase & Co
JPM.N , Citigroup Inc C.N , Bank of America Corp BAC.N ,
Wells Fargo & Co WFC.N and Goldman Sachs Group Inc GS.N were
up between 0.6% and 0.5%.
Altimmune Inc ALT.O slipped 10.5% after the U.S. Food and
Drug Administration issued a clinical hold on the drug
developer's application to begin human testing of its
single-dose COVID-19 vaccine, AdCOVID.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.